Thailand's H1N1 Flu Vaccine Maker Offers Trial Guidelines
This article was originally published in PharmAsia News
Executive Summary
Thailand's Government Pharmaceutical Organization is issuing guidelines expected to limit clinical trials for its H1N1 flu vaccine to 430 volunteers between the age of 12 and 49 years old. The GPO plans to begin producing a nasal spray vaccine in August and to launch a four-month trial in September. The GPO drug represents Thailand's first attempt to make a vaccine from a live virus, developed under the aegis of the World Health Organization. (Click here for more